Progression of a focal ischemic lesion in rat brain during treatment with a novel glycine/NMDA antagonist: an in vivo three-dimensional diffusion-weighted MR microscopy study

J Magn Reson Imaging. 1997 Jul-Aug;7(4):739-44. doi: 10.1002/jmri.1880070421.

Abstract

Stroke was induced in two groups of anesthetized rats by occlusion of the middle cerebral artery (MCA) and ipsilateral common carotid artery. Group 1 (control) received vehicle and group 2 received the glycine N-methyl-D-aspartate (NMDA) antagonist ZD9379. Stroke volume was assessed by three-dimensional diffusion-weighted MR microscopy at 2.5 and 6 hours of MCA occlusion. At 2.5 hours, stroke volumes were identical in the two groups. At 6 hours, stroke volumes had increased by 15% in the control group; in contrast, the treated group showed a 40% reduced stroke volume. Conclusions from this in vivo study were as follows: (a) our technique allows more efficient and accurate measurement of stroke volume with an improvement in resolution over a previous method; (b) the ability to measure stroke volume at multiple time points shows volume change and assessment of time dependency of drug treatment; (c) at 6 hours, the glycine antagonist ZD9379 reduced stroke volume by 40%.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain / pathology*
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / pathology
  • Female
  • Image Processing, Computer-Assisted / methods
  • Magnetic Resonance Imaging / methods*
  • Pyridazines / therapeutic use*
  • Quinolines / therapeutic use*
  • Rats
  • Rats, Inbred F344
  • Receptors, Glycine / antagonists & inhibitors*
  • Time Factors

Substances

  • Pyridazines
  • Quinolines
  • Receptors, Glycine
  • ZD 9379